CS logo
small CS logo
Global Clinical Trials

Pretoria, South Africa

About Global Clinical Trials


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Global Clinical Trials


During the past decade, Global Clinical Trials conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Global Clinical Trials" #1 sponsor was "Merz Pharmaceuticals GmbH" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "BioNTech SE" with 1 trials sponsored, "Clover Biopharmaceuticals AUS Pty Ltd" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Global Clinical Trials" #1 collaborator was "Teva Pharmaceutical Industries, Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Global Clinical Trials


According to Clinical.Site data, the most researched conditions in "Global Clinical Trials" are "COVID-19" (6 trials), "SARS-CoV2 Infection" (2 trials), "Subjective Tinnitus" (2 trials), "Coronavirus" (1 trials) and "Coronavirus Infection" (1 trials). Many other conditions were trialed in "Global Clinical Trials" in a lesser frequency.

Clinical Trials Intervention Types at Global Clinical Trials


Most popular intervention types in "Global Clinical Trials" are "Drug" (7 trials), "Biological" (4 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Neramexane mesylate" (2 trials), "BNT162b2" (1 trials), "BNT162b2 (B.1.1.529)" (1 trials) and "BNT162b2 (B.1.1.7 + B.1.617.2)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Global Clinical Trials


The vast majority of trials in "Global Clinical Trials" are 11 trials for "All" genders.

Clinical Trials Status at Global Clinical Trials


Currently, there are NaN active trials in "Global Clinical Trials". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Global Clinical Trials, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Global Clinical Trials, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".